Cargando…
Systemic Immunomodulatory Treatments for Atopic Dermatitis: Update of a Living Systematic Review and Network Meta-analysis
IMPORTANCE: Systemic treatments for atopic dermatitis are being evaluated primarily in placebo-controlled trials; network meta-analysis can provide relative efficacy and safety estimates for treatments that have not been compared head to head. OBJECTIVE: To compare reported measures of efficacy and...
Autores principales: | Drucker, Aaron M., Morra, Deanna E., Prieto-Merino, David, Ellis, Alexandra G., Yiu, Zenas Z. N., Rochwerg, Bram, Di Giorgio, Sonya, Arents, Bernd W. M., Burton, Tim, Spuls, Phyllis I., Schmitt, Jochen, Flohr, Carsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928094/ https://www.ncbi.nlm.nih.gov/pubmed/35293977 http://dx.doi.org/10.1001/jamadermatol.2022.0455 |
Ejemplares similares
-
Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis: A Systematic Review and Network Meta-analysis
por: Drucker, Aaron M., et al.
Publicado: (2020) -
Systemic immunomodulatory treatments for atopic dermatitis: protocol for a systematic review with network meta-analysis
por: Drucker, Aaron Mark, et al.
Publicado: (2018) -
Work ability and quality of working life in atopic dermatitis patients treated with dupilumab
por: Bosma, Angela L., et al.
Publicado: (2021) -
Biomarkers associated with the development of comorbidities in patients with atopic dermatitis: A systematic review
por: Broderick, Conor, et al.
Publicado: (2022) -
Development of a Website for a Living Network Meta-analysis of Atopic Dermatitis Treatments Using a User-Centered Design: Multimethod Study
por: Lau, Karen P L, et al.
Publicado: (2022)